OBSERVED METADATA
Headline history
Capture times describe when MedWorld411 observed this metadata. They do not establish when a publisher edited an article.
Revision 1
FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease
FDA · Observed Nov 20, 2026, 9:50 PM EST